cas 53332-67-5|| where to buy C-(1-Methyl-1H-imidazol-2-yl)-methylaminedihydrochloride

Nombre del producto:C-(1-Methyl-1H-imidazol-2-yl)-methylaminedihydrochloride

IUPAC Name:1-(1-methyl-1H-imidazol-2-yl)methanamine dihydrochloride

Unidad de embalaje	Stock disponible	Precio($)	Cantidad
CM186980-1g	in stock	ƞźș

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 53332-67-5 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :53332-67-5; Fórmula molecular:C5H11Cl2N3; Punto de fusión:-; Código de sonrisas:NCC1=NC=CN1C.[H]Cl.[H]Cl; Densidad:

: Número de catálogo:CM186980; Peso molecular:184.06; Punto de ebullición:; Nº Mdl:MFCD09431497; Almacenamiento:Store at room temperature.

: Imidazoles; Imidazole is an important five-membered nitrogen-containing heterocyclic compound. Among the numerous heterocyclic compounds, imidazole and its derivatives are regarded as a unique and multifaceted scaffold material due to their diverse applications in industrial, organic and pharmaceutical chemistry. Imidazoles interact in different ways with many therapeutic targets, enzymes and receptors in biological systems and thus exhibit a wide range of biological activities. In particular, several imidazoles can be used as clinical drugs to treat various types of cancer with high therapeutic efficacy. Furthermore, imidazoles are one of the most critical segments in the field of anti-covid-19 virus drug discovery due to their ability to interact with active targets in living systems.; Imidazole Manufacturer; As a professional imidazole manufacturer, we can guarantee product quality and delivery time.our company has been committed to supply personalized product solutions to customers,pls consult us.